The prevention of pneumococcal disease by vaccines: Promises and challenges

被引：17

作者：

Poland, GA ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Dept Internal Med, Clin Pharmacol Unit, Mayo Vaccine Res Grp, Rochester, MN 55905 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2001年 / 15卷 / 01期

关键词：

D O I：

10.1016/S0891-5520(05)70270-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Pneumococcal vaccines offer both promises in disease prevention and challenges in terms of deploying current vaccines and developing;the next generation of vaccines. With the recent breakthrough licensure of a pneumococcal conjugate vaccine for routine use in children under the age of 5 years, this article reviews and updates the reader on issues surrounding pneumococcal vaccines and on the current results of pneumococcal conjugate vaccine trials.

引用

页码：97 / +

页数：27

共 141 条

[1]

*ACP TASK FORC AD, 1994, GUID AD IMM, P2

[2] DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA [J].

ADAMS, WG ;

DEAVER, KA ;

COCHI, SL ;

PLIKAYTIS, BD ;

ZELL, ER ;

BROOME, CV ;

WENGER, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02) :221-226

[3]

ALMOHSEN I, 1995, 35 ICAAC C, pH46

[4]

Amer Diabet Assoc, 2000, DIABETES CARE, V23, P109

[5] Parallel factorization of banded linear matrices using a systolic array processor [J].

Anderson, IJ ;

Harbour, SK .

ADVANCES IN COMPUTATIONAL MATHEMATICS, 1996, 5 (01) :1-14

[6]

ANDERSON U, 1989, AUDITING-J PRACT TH, V8, P1

[7]

[Anonymous], 1999, MMWR Recomm Rep, V48, P1

[8]

[Anonymous], 1997, MMWR Recomm Rep, V46, P1

[9]

[Anonymous], MMWR MORB MORTAL WKL

[10]

Austrian R, 1976, Trans Assoc Am Physicians, V89, P184

← 1 2 3 4 5 6 7 8 9 10 →